Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega‐3 intake

Abstract

Newly described lipoxygenase (LOX)-generated lipid mediators, that is, resolvins and protectins as well as lipoxins, are both anti-inflammatory and proresolving. We aimed to determine whether these lipid mediators are present in bone marrow and whether their lipidomic profiles are altered following ovariectomy or dietary supplementation with eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) ethyl esters. Female rats were ovariectomised or sham-operated. Shams and one ovariectomised group received a diet devoid of omega-3 long-chain polyunsaturated fatty acids. The remaining ovariectomised rats received either 0.5 g EPA or DHA ethyl ester/kg body weight/day for 4 months. Bone marrow was analyzed using both GC to determine fatty acid composition and mediator lipidomics by LC/MS/MS profiling for the presence of LOX-pathway lipid mediators derived from arachidonic acid (AA), EPA, and DHA. LOX-derived products including lipoxins, resolvin D1, resolvin E1, and protectin D1 were identified in bone marrow by the presence of diagnostic ions in their corresponding MS-MS spectra. The proportion of AA relative to DHA and of AA-derived relative to DHAderived mediators in bone marrow was higher in ovariectomised compared to sham-operated rats. DHA or EPA ethyl ester supplementation increased the percentage of DHA and EPA in bone marrow and increased the proportion of LOX mediators biosynthesized from DHA or EPA, respectively. Given the potent bioactivities of the lipoxins, resolvins, and protectins, the presence and changes in profile postovariectomy and with EPA and DHA ethyl ester supplementation may be of interest in bone marrow function and as a potential source of these mediators in vivo. Am. J. Hematol. 83:437-445, 2008. V

Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1

“…In addition, PD1 was found to be a major product in bone marrow of female rats fed eicosapentaenoic acid and DHA ( 67 ). PD1 was generated in vivo during ischemia-reperfusion of renal tissues, where it has profound actions, namely reversing the deleterious consequences of ischemia-reperfusion in renal tissues ( 68 ), in agreement with our previous observations in the brain ( 47 ).…”

Bioactive lipid mediators in polycystic kidney disease

“…The EPA-derived HEPE metabolites even have anti-inflammatory properties ( 70,71 ). Interestingly, we observed a bell-shaped concentration distribution of HEPE compounds, with these compounds being higher in patients with TKVs of 800-1,500 ml than in those with TKVs <800 ml or TKVs above 1,500 ml.…”

Long-chain polyunsaturated fatty acids: Selected mechanisms of action on bone

“…LCPUFAs have been shown to affect cellular proteins and receptor activator of nuclear factor κβ (RANK), a receptor found on the osteoclast which controls osteoclastogenesis. This will be discussed in detail below [25][26][27].…”

“…DHA and EPA supplementation of OVX rats increased the percentage of EPA and DHA in the bone marrow and increased the proportion of LOX mediators generated from DHA and EPA respectively. These changes in mediator profile due to OVX and subsequent improvement of anti-inflammatory mediator levels may have consequences for bone metabolism [25].…”